Cord blood graft composition impacts the clinical outcome of allogeneic stem cell transplantation

Transplant Infectious Disease

Volumn 16, Issue 2, 2014, Pages 203-212

  Wikell, H ^a,b   Ponandai Srinivasan, S ^a   Mattsson, J ^a,b   Gertow, J ^a,b   Uhlin, M ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Allogeneic stem cell transplantation; Clinical outcome; Cord blood; Graft composition

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45RO ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; CD94 ANTIGEN; CHEMOKINE RECEPTOR CCR7; FAS ANTIGEN; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 7 RECEPTOR ALPHA; LECTIN; LEUKOCYTE ANTIGEN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY D; T LYMPHOCYTE ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BACTEREMIA; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMPOSITION; CHILD; CLINICAL ARTICLE; CORRELATION ANALYSIS; CYTOTOXIC T LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; HERPES SIMPLEX VIRUS; HERPES VIRUS; HUMAN; MALE; OUTCOME ASSESSMENT; PHENOTYPE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; RELAPSE; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE SUBPOPULATION; UMBILICAL CORD BLOOD; VARICELLA ZOSTER VIRUS; VIRUS REACTIVATION; ALLOTRANSPLANTATION; B LYMPHOCYTE; CHEMISTRY; CYTOLOGY; FETUS BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; INFANT; LYMPHOCYTE COUNT; MIDDLE AGED; PHYSIOLOGY; PRESCHOOL CHILD; SIMPLEXVIRUS; SURVIVAL RATE; T LYMPHOCYTE; VIRUS ACTIVATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, CD95; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; FETAL BLOOD; FLOW CYTOMETRY; GRAFT REJECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 3, HUMAN; HUMANS; INFANT; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; LECTINS, C-TYPE; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D; SIMPLEXVIRUS; SURVIVAL RATE; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; VIRUS ACTIVATION; YOUNG ADULT;

EID: 84897962190     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12182     Document Type: Article

References (40)

1. Frey MA, Guess C, Allison J, Kurtzberg J. Umbilical cord stem cell transplantation. Semin Oncol Nursing 2009; 25 (2): 115-119.
2. Mattsson J. Recent progress in allogeneic stem cell transplantation. Curr Opin Molecu Therapeutics 2008; 10 (4): 343-349.
3. Wagner JE, Gluckman E. Umbilical cord blood transplantation: the first 20 years. Semin Hematol 2010; 47 (1): 3-12.
4. Escalon MP, Komanduri KV. Cord blood transplantation: evolving strategies to improve engraftment and immune reconstitution. Curr Opin Oncol 2010; 22 (2): 122-129.
5. McKenna DH, Brunstein CG. Umbilical cord blood: current status and future directions. Vox Sang 2011; 100 (1): 150-162.
6. Zhong XY, Zhang B, Asadollahi R, Low SH, Holzgreve W. Umbilical cord blood stem cells: what to expect. Ann New York Acad Sci 2010; 1205 : 17-22.
7. Rocha V, Gluckman E. Clinical use of umbilical cord blood hematopoietic stem cells. Biol Blood Marrow Transplant 2006; 12 (1 Suppl 1): 34-41.
8. Barker JN, Rocha V, Scaradavou A. Optimizing unrelated donor cord blood transplantation. Biol Blood Marrow Transplant 2009; 15 (1 Suppl): 154-161.
9. de la Hoz RE, Stephens G, Sherlock C. Diagnosis and treatment approaches of CMV infections in adult patients. J Clinic Virol 2002; 25 (Suppl 2): S1-S12.
10. Sauerbrei A, Schmitt S, Scheper T, et al. Seroprevalence of herpes simplex virus type 1 and type 2 in Thuringia, Germany, 1999 to 2006. Euro Surveill 2011; 16 (44); pii: 20005.
11. Reddy SM, Winston DJ, Territo MC, Schiller GJ. CMV central nervous system disease in stem-cell transplant recipients: an increasing complication of drug-resistant CMV infection and protracted immunodeficiency. Bone Marrow Transplant 2010; 45 (6): 979-984.
12. Heemskerk B, Lankester AC, van Vreeswijk T, et al. Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients. J Infect Dis 2005; 191 (4): 520-530.
13. Omar H, Hagglund H, Gustafsson-Jernberg A, et al. Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction. Transpl Infect Dis 2009; 11 (5): 393-399.
14. Ringden O, Okas M, Uhlin M, Uzunel M, Remberger M, Mattsson J. Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor. Bone Marrow Transplant 2008; 42 (10): 643-648.
15. Okas M, Gertow J, Uzunel M, et al. Clinical expansion of cord blood-derived T cells for use as donor lymphocyte infusion after cord blood transplantation. J Immunother 2010; 33 (1): 96-105.
16. Berglund S, Le Blanc K, Remberger M, et al. Factors with an impact on chimerism development and long-term survival after umbilical cord blood transplantation. Transplantation 2012; 94 (10): 1066-1074.
17. Nakamura R, Bahceci E, Read EJ, et al. Transplant dose of CD34(+) and CD3(+) cells predicts outcome in patients with haematological malignancies undergoing T cell-depleted peripheral blood stem cell transplants with delayed donor lymphocyte add-back. Br J Haematol 2001; 115 (1): 95-104.
18. Panse JP, Heimfeld S, Guthrie KA, et al. Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioning. Br J Haematol 2005; 128 (5): 659-667.
19. Tsirigotis P, Shapira MY, Or R, et al. The number of infused CD34+ cells does not influence the incidence of GVHD or the outcome of allogeneic PBSC transplantation, using reduced-intensity conditioning and antithymocyte globulin. Bone Marrow Transplant 2010; 45 (7): 1189-1196.
20. Schmitz N, Beksac M, Hasenclever D, et al. Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia. Blood 2002; 100 (3): 761-767.
21. Matsumura T, Narimatsu H, Kami M, et al. Cytomegalovirus infections following umbilical cord blood transplantation using reduced intensity conditioning regimens for adult patients. Biol Blood Marrow Transplant 2007; 13 (5): 577-583.
22. Prasad VK, Mendizabal A, Parikh SH, et al. Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood 2008; 112 (7): 2979-2989.
23. Scaradavou A, Brunstein CG, Eapen M, et al. Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia. Blood 2013; 121 (5): 752-758.
24. Kindwall-Keller TL, Hegerfeldt Y, Meyerson HJ, et al. Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies. Bone Marrow Transplant 2012; 47 (7): 924-933.
25. Gertow J, Berglund S, Okas M, et al. Expansion of T-cells from the cord blood graft as a predictive tool for complications and outcome of cord blood transplantation. Clin Immunol 2012; 143 (2): 134-144.
26. Uhlin M, Masucci MG, Levitsky V. Regulation of lck degradation and refractory state in CD8+ cytotoxic T lymphocytes. Proc National Acad Sci USA 2005; 102 (26): 9264-9269.
27. Lopez-Cabrera M, Santis AG, Fernandez-Ruiz E, et al. Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors. J Exp Med 1993; 178 (2): 537-547.
28. Parrish YK, Baez I, Milford TA, et al. IL-7 dependence in human B lymphopoiesis increases during progression of ontogeny from cord blood to bone marrow. J Immunol 2009; 182 (7): 4255-4266.
29. Dean RM, Fry T, Mackall C, et al. Association of serum interleukin-7 levels with the development of acute graft-versus-host disease. J Clin Oncol 2008; 26 (35): 5735-5741.
30. Mingari MC, Ponte M, Cantoni C, et al. HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes: molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells. Int Immunol 1997; 9 (4): 485-491.
31. De Maria A, Ferraris A, Guastella M, et al. Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functions. Proc National Acad Sci USA 1997; 94 (19): 10285-10288.
32. Suvas S, Azkur AK, Rouse BT. Qa-1b and CD94-NKG2a interaction regulate cytolytic activity of herpes simplex virus-specific memory CD8+ T cells in the latently infected trigeminal ganglia. J Immunol 2006; 176 (3): 1703-1711.
33. Bouillet P, O'Reilly LA. CD95, BIM and T cell homeostasis. Nat Rev Immunol 2009; 9 (7): 514-519.
34. Dobbs ME, Strasser JE, Chu CF, Chalk C, Milligan GN. Clearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin- or Fas-mediated cytolytic mechanisms. J Virol 2005; 79 (23): 14546-14554.
35. Juchem KW, Anderson BE, Zhang C, et al. A repertoire-independent and cell-intrinsic defect in murine GVHD induction by effector memory T cells. Blood 2011; 118 (23): 6209-6219.
36. Dutt S, Tseng D, Ermann J, et al. Naive and memory T cells induce different types of graft-versus-host disease. J Immunol 2007; 179 (10): 6547-6554.
37. Yakoub-Agha I, Saule P, Depil S, et al. A high proportion of donor CD4+ T cells expressing the lymph node-homing chemokine receptor CCR7 increases incidence and severity of acute graft-versus-host disease in patients undergoing allogeneic stem cell transplantation for hematological malignancy. Leukemia 2006; 20 (9): 1557-1565.
38. Foster AE, Marangolo M, Sartor MM, et al. Human CD62L- memory T cells are less responsive to alloantigen stimulation than CD62L+ naive T cells: potential for adoptive immunotherapy and allodepletion. Blood 2004; 104 (8): 2403-2409.
39. Chen YB, McDonough S, Hasserjian R, et al. Expression of CD30 in patients with acute graft-versus-host disease. Blood 2012; 120 (3): 691-696.
40. Gertow J, Berglund S, Okas M, et al. Characterization of long-term mixed donor-donor chimerism after double cord blood transplantation. Clin Exper Immunol 2010; 162 (1): 146-155.